Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ADMA Biologics Announces CFO Transition
-
Monster Beverage Reports 2023 Fourth Quarter and Full-Year Financial Results
-
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
-
Altus Group Nominates Jim Hannon and Will Brennan to its Board of Directors
-
Orion Group Holdings Reports Fourth Quarter and Full Year 2023 Results
-
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2023
-
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
-
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
-
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
Trupanion to Participate in the Raymond James 2024 Institutional Investors Conference
-
Lightbridge Provides Business Update and Announces Fiscal Year 2023 Financial Results
-
Inari Medical Reports Fourth Quarter 2023 Financial Results
-
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
-
Pool Corporation Declares Quarterly Cash Dividend
-
Grindrod Shipping Holdings Ltd. Announces Unaudited Financial Results for the Second Half and Full Year Ended December 31, 2023
-
Marathon Digital Holdings Introduces Anduro, a New Multi-Chain Bitcoin Layer-Two Network
-
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
-
Magnite Reports Fourth Quarter and Full-Year 2023 Results
-
James River Announces Fourth Quarter 2023 Results
-
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
-
Pennant Reports Fourth Quarter and Fiscal Year 2023 Results
-
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
-
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
MPA Delivery Partners Selected for Hudson Tunnel Project, The Most Urgent Infrastructure Project in the U.S.
-
Sovos Brands Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Climb Global Solutions Reports Fourth Quarter and Full Year 2023 Results
-
BBSI Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
-
Alkami Announces Fourth Quarter 2023 Financial Results
-
Euroseas Ltd. Announces Two-Year Time Charter Contract for its Fuel Efficient 2,800 teu Feeder Containership Newbuilding, M/V Leonidas Z, Commencing upon its Delivery
-
EverQuote to Participate in Upcoming Investor Conferences
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
-
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
-
Spencer Fane Enters Nation’s Second Largest Legal Market with Patent Litigation Group
-
Toll Brothers Announces New Luxury Home Community to Open Soon in Hopkinton, Massachusetts
-
WW International, Inc. Announces Upcoming Oprah Winfrey Board Transition
-
Green Thumb Industries Reports Fourth Quarter and Full Year 2023 Results
-
Duolingo Reports 65% DAU Growth, 45% Revenue Growth and Record Profitability in Fourth Quarter 2023
-
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
-
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
-
WW International, Inc. Announces Fourth Quarter and Full Year 2023 Results
-
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
-
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
-
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
-
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

